Markets:

Overview

News

Currencies

International

Treasuries

Qiagen N.V. Common Shares (NY:QGEN)

50.41 -0.44 (-0.87%)

Official Closing Price Updated: 7:00 PM EST, Feb 13, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Qiagen N.V. Common Shares

< Previous 1 2 3 4 Next >

Earnings Preview: Qiagen ↗

February 05, 2024

Via Benzinga

Goldman Sachs Upgrades Twist Bioscience, Says Express Genes Launch Will Drive Margin Expansion ↗

January 17, 2024

Goldman Sachs upgrades Twist Bioscience as Express Genes launch addresses SynBio division's gross margin issues. With 5-7 days gene delivery, TWST taps into a previously inaccessible market, enhancing...

Via Benzinga

Qiagen's Health Odyssey: Expanding In Riyadh And Partnering In Public Projects ↗

January 03, 2024

QIAGEN N.V. (NYSE: QGEN) disclosed its expansion plan in

Via Benzinga

Qiagen Has Steady Income And Defensive Growth Potential, Goldman Sachs Upgrades Stock ↗

December 07, 2023

Qiagen NV (NYSE: QGEN) has a steady income from selling tools for preparing samples and diagnostics.

Via Benzinga

Where Qiagen Stands With Analysts ↗

December 07, 2023

Via Benzinga

These Companies Helped The German DAX Index Hit Its All-time High ↗

December 06, 2023

The DAX 40 index surged to its all-time high on Tuesday, continuing the remarkable rally that started on October 23rd. The index, which tracks the 40 biggest companies in Germany, soared to a high of...

Via Talk Markets

Analyst Expectations for Qiagen's Future ↗

November 02, 2023

Via Benzinga

Preview: Qiagen's Earnings ↗

October 27, 2023

Via Benzinga

Analyst Expectations for Qiagen's Future ↗

October 17, 2023

Via Benzinga

Diagnostic Firm Qiagen's Q3 Earnings: Analyst Says Annual Projections Attainable Despite Macro Trends ↗

October 31, 2023

Qiagen NV's (NASDAQ: QGEN) Q3 net sales of $470 million at constant exchange rates (CER) for Q3 2023 were above the outlook for at least $465 million CER, driven by 5% CER growth in the

Via Benzinga

Biden Administration Restarts Distribution Of Free At Home COVID-19 Tests, After Suspending For Year ↗

September 21, 2023

In response to the escalating spread of the virus nationwide, the Biden administration declared that it would recommence offering free at-home COVID tests to American households starting next Monday.

Via Benzinga

The 3 Most Promising Biotech Stocks to Buy Now ↗

March 21, 2023

With the NIH requesting its biggest budget yet, these are the three most promising healthcare stocks to buy now.

Via InvestorPlace

Genetic Technologies Shares Jump After Strategic Alliance With Qiagen ↗

February 01, 2023

Genetic Technologies Limited (NASDAQ: GENE) agreed to form a strategic alliance with Qiagen NV (NYSE: QGEN) to establish and develop a 'Centre of Excellence facility in Australia.

Via Benzinga

Will Investors Notice Exciting Sign On Qiagen's Chart? ↗

December 20, 2022

Via Benzinga

QIAGEN Launches Syndromic Test For QIAstat-Dx For Six Pathogens Similar To Monkeypox ↗

August 16, 2022

Via Benzinga

Earnings Scheduled For October 30, 2023 ↗

October 30, 2023

Companies Reporting Before The Bell • HSBC Holdings (NYSE:HSBC) is likely to report earnings for its third quarter.

Via Benzinga

Will Chart Analysts Notice Bad Omen on Qiagen's Chart ↗

April 11, 2023

Via Benzinga

Stocks That Hit 52-Week Lows On Tuesday ↗

September 19, 2023

During Tuesday's session, 275 companies made new 52-week lows.

Via Benzinga

Tesla's Delivery Wait Times Go Up, China Wants To Secure License For Generic Version Of Pfizer's Paxlovid, India-Made iPhone Exports Surpass $2.5B: Today's Top Stories ↗

January 09, 2023

Bloomberg

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For September 12, 2023 ↗

September 12, 2023

Via Benzinga

QIAGEN Acquires Verogen Strengthening Its Position In Human ID / Forensics ↗

January 09, 2023

Via Benzinga

A Preview Of Qiagen's Earnings ↗

November 04, 2022

Qiagen (NYSE:QGEN) is set to give its latest quarterly earnings report on Monday, 2022-11-07. Here's what investors need to know before the announcement. Analysts estimate that Qiagen will report an...

Via Benzinga

Earnings Scheduled For November 7, 2022 ↗

November 07, 2022

Companies Reporting Before The Bell • NAPCO Security Techs (NASDAQ:NSSC) is expected to report quarterly earnings at $0.13 per share on revenue of $36.34 million.

Via Benzinga

Why Bio-Rad Laboratories' Rumored $10 Billion Qiagen Buyout Looks Unlikely ↗

October 11, 2022

One analyst doubts any deal could come to fruition. If it did, it would make sense.

Via Investor's Business Daily

Twitter May Drop Clickable Hashtags, AstraZeneca's Nasal COVID-19 Vaccine Fails Trial, Coinbase Gets Singapore Nod: Top Stories Tuesday, Oct. 11 ↗

October 11, 2022

Reuters US-China Chip War: KLA Relaxes Chip Supply To China

Via Benzinga

Bio-Rad Laboratories, Qiagen Mull Merger Of Equals ↗

October 11, 2022

Bio-Rad Laboratories Inc (NYSE: BIO) is reportedly in talks to merge with Qiagen NV (NYSE: QGEN), but any agreement isn't likely for another few weeks or more, or it may not happen at all.

Via Benzinga

FDA To Review Smaller Number Of Emergency Use Requests For COVID-19 Tests ↗

September 27, 2022

Via Benzinga

COVID-19 Complacency Pushes Identification Of New Variants To Back Seat, WHO Warns ↗

September 23, 2022

The World Health Organization (WHO) warned that it struggles to identify and

Via Benzinga

No More Free COVID-19 At-Home Tests, Federal Government Says ↗

August 29, 2022

CNBC reported that the federal government is set to suspend its offer of free at-home COVID-19 tests by Friday, September 2, without congressional au

Via Benzinga

Qiagen Posts Robust Q2 Non-COVID Sales Growth, Lifts Annual Guidance ↗

July 27, 2022

Qiagen N.V. (NYSE: QGEN) clocked Q2 FY22 revenues of $516 million, down 9% Y/Y, well above the consensus of $488.73 million.

Via Benzinga

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Qiagen N.V. Common Shares (NY:QGEN)

Headline News about Qiagen N.V. Common Shares

Starting at $3.75/week.

Subscribe Today